Business Context and Reporting Period
Company: Albemarle Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2006
Business Overview: Albemarle is a global developer, manufacturer, and marketer of highly engineered specialty chemicals, operating through three primary segments: Polymer Additives, Catalysts, and Fine Chemicals.
Key Financial Metrics
Revenue and Profitability (Nine Months Ended Sept 30, 2006):
- Net Sales: $1,784.0 million (up 17% vs. prior year).
- Gross Profit: $402.1 million (margin of 22.5%, up from 20.5% in 2005).
- Operating Profit: $100.6 million (down from $124.4 million in 2005 due to divestiture charges).
- Net Income: $80.0 million (down 3% vs. prior year).
- Diluted Earnings Per Share (EPS): $1.65 (down from $1.74 in 2005).
Liquidity and Balance Sheet (As of Sept 30, 2006):
- Cash and Cash Equivalents: $89.6 million (up from $58.6 million at year-end 2005).
- Total Assets: $2,612.7 million.
- Total Debt: $785.0 million (Current: $51.7 million; Long-term: $733.2 million).
- Shareholders' Equity: $1,029.7 million.
Cash Flow (Nine Months Ended Sept 30, 2006):
- Operating Cash Flow: $215.9 million (up significantly from $94.0 million in 2005).
- Investing Cash Flow: $(115.6) million (primarily capital expenditures of $73.1 million and a $25.0 million acquisition).
- Financing Cash Flow: $(72.0) million (net of debt repayments, stock repurchases, and dividends).
Material Changes vs. Prior Period
Third Quarter 2006 Highlights:
- Net Sales: $607.8 million (up 20% vs. Q3 2005), driven by 11% price increases and 9% volume growth.
- Net Income: $2.3 million (down 91% vs. Q3 2005's $26.3 million).
- Primary Driver of Decline: A one-time pre-tax charge of $89.2 million ($58.4 million after-tax) related to the divestiture of the Thann, France facility.
- Effective Tax Rate: 115.2% for the quarter (vs. 15.7% in 2005), heavily influenced by the tax benefit associated with the Thann charge.
Segment Performance (Nine Months):
- Polymer Additives: Sales up 16%; Segment income up 51% to $109.0 million.
- Catalysts: Sales up 31%; Segment income up 45% to $93.1 million.
- Fine Chemicals: Sales up 4%; Segment loss of $49.5 million (includes the $89.2 million Thann charge). Excluding the charge, income was $39.7 million.
Guidance, Outlook, and Risks
Management Commentary and Outlook:
- Thann Divestiture: Completed August 31, 2006. Expected net after-tax cash costs to be less than $10.0 million.
- Acquisition: Acquired DSM Pharmaceutical Products' South Haven, Michigan facility for approximately $25.0 million to expand fine chemistry services.
- Capital Expenditures: 2006 spending expected to be ~$110 million; 2007-2008 expected to be $90-$100 million annually.
- Segment Outlook:
- Polymer Additives: Stable volumes expected; new phosphorous flame retardant plant in Nanjing, China, targeted for H2 2007.
- Catalysts: New HPC catalysts plant in Bayport, Texas, expected operational in Q2 2007. Focus on margin recovery via pricing.
- Fine Chemicals: Turnaround expected in Q4 2006; focus on bromine franchise and fine chemistry services.
Risks and Contingencies:
- Environmental: Received a Notice of Violation (NOV) from the EPA regarding the Orangeburg, SC plant. Potential fines or capital expenditures are possible but not expected to be material. Recorded environmental liabilities are $29.7 million, with a reasonable possibility of up to $14.0 million in additional costs.
- Legal: Arbitration regarding the Thann facility was transferred to the new owner (ICIG) upon divestiture.
- Market Risks: Exposure to raw material/energy costs, foreign currency fluctuations, and interest rate changes on variable-rate debt ($380.2 million outstanding).
Investor Verification Checklist
- Thann Divestiture Impact: Verify the $89.2 million charge is fully accounted for and confirm the expected cash outflow remains under $10.0 million.
- Excluding Special Items: Review operating performance excluding the Thann charge to assess underlying business health (e.g., Fine Chemicals segment income was positive excluding the charge).
- Debt Covenants: Confirm continued compliance with the fixed charge coverage ratio (1.25:1) and debt-to-capitalization ratio (60%) covenants.
- Capital Allocation: Monitor the execution of the $25.0 million DSM acquisition and the $110 million capital expenditure program.
- Environmental Liabilities: Track the resolution of the EPA Notice of Violation in Orangeburg, SC, and any potential accruals for environmental remediation.